Result Summary for 759346/007
| Protocol ID: | 759346/007 |
| Clinical Study ID: | 759346/007 |
| Official Title: | Demonstrate non-inferiority of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ with respect to anti-HBs immune response, when given to healthy infants at 6,10 & 14 wks age, after a birth dose of hepatitis B vaccine |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | Hepatitis B Vaccine, Recombinant |
| Trade/Product Name: | Engerix-B |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
